INTERNATIONAL PATENT: PAM THERAGNOSTICS GMBH FILES APPLICATION FOR "ANTI-ADM ANTIBODIES, ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR THERAPY OR PREVENTION OF IMMUNE EFFECTOR CELL THERAPY SIDE EFFECTS"

GENEVA, March 9 -- PAM THERAGNOSTICS GMBH (Neuendorfstr. 15 B16761 Hennigsdorf) filed a patent application (PCT/EP2025/074246) for "ANTI-ADM ANTIBODIES, ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR THERAPY OR PREVENTION OF IMMUNE EFFECTOR CELL THERAPY SIDE EFFECTS" on Aug 26, 2025. With publication no. WO/2026/046978, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KAUFMANN, Paul (c/o PAM Theragnostics GmbH, Neuendorfstr. 15 B16761 Hennigsdorf), ILINA, Yulia (c/o PAM Theragnostics GmbH, Neuendorfstr. 15 B167...